Skip to main content
nDatalyze Corp. logo

nDatalyze Corp. — Investor Relations & Filings

Ticker · NDAT ISIN · CA63948H1055 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 282 across all filing types
Latest filing 2020-05-15 Regulatory Filings
Country CA Canada
Listing CSE NDAT

About nDatalyze Corp.

https://ndatalyze.com/

nDatalyze Corp. specializes in generating technology-based, health-related solutions through the application of machine learning (ML) to specialized records databases. The company's primary focus is the development and licensing of applications designed to predict probable mental health conditions and performance predispositions. Utilizing guided ML processes, the technology analyzes complex factors including nature/nurture correlations, genetic predispositions, and environmentally-calibrated data to establish intelligent mind/body correlations necessary for achieving peak performance. Core offerings include the SIGMUND Mental Performance application and EPITOME Hockey.

Recent filings

Filing Released Lang Actions
Audited annual financial statements – English.pdf
Regulatory Filings
2020-05-15 English
News release - English.pdf
AGM Information Classification · 100% confidence The document is an invitation notice for the Annual General Meeting (AGM) of Savaria Corporation, detailing the date, location, agenda items such as receiving audited financial statements, electing directors, appointing auditors, and voting procedures. It includes instructions for shareholders on how to participate, vote by proxy, and access related documents online. The content is focused on the meeting logistics and shareholder participation rather than presenting financial results or detailed reports. Therefore, this document fits the category of AGM Information (AGM-R). The document length is about 5032 characters, consistent with a detailed AGM notice but not a full report.
2020-04-06 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated April 6, 2020, providing an operational update from MedXtractor Corp. It discusses recent sales performance, the impact of COVID-19, cash position, product development, and potential M&A activity. It explicitly states that audited financials for the fiscal year ending February 29, 2020, will be released when available, indicating this is not the financial report itself. The document is short (4744 characters) and serves as an update rather than containing detailed financial statements or comprehensive analysis. There is no indication of it being a call transcript, management report, or other specific filing. It is an operational update press release, which fits best under Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2020-04-06 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a distribution agreement between MedXtractor Corp. and Purpl Scientific Inc. It contains no financial statements, no regulatory form references, no voting results, no management or board changes, and no mention of report publication. The content is a business update about a commercial agreement, typical of a Capital/Financing Update or general corporate announcement. Given the nature of the announcement about a distribution agreement and no indication of financing or capital raising, the closest fitting category is Capital/Financing Update (CAP). The document length is under 5,000 characters and is a standalone announcement, not a report or regulatory filing. Therefore, the classification is CAP with high confidence.
2020-03-05 English
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a press release announcing the company's financial results for the quarter ended November 30, 2019 (Q3 2020 fiscal quarter). It mentions the release of unaudited interim condensed financial statements and Management's Discussion and Analysis (MD&A) filed on SEDAR, but the document itself is a summary announcement highlighting key financial metrics and operational commentary. It does not contain detailed financial statements or substantive financial data itself, only a summary of results and forward-looking statements. The document length is 4858 characters, which is relatively short and consistent with a press release or earnings announcement rather than a full interim report. Therefore, this document fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. Q3 2020
2020-01-09 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'MedXtractor Corp. Management Discussion and Analysis for the three and nine months ended November 30, 2019 Unaudited.' It contains detailed operational and financial results, including revenues, expenses, and net income/loss for the specified interim periods. The text includes management's analysis of business operations, financial performance, and forward-looking statements. It references unaudited interim condensed financial statements prepared under IFRS. The document length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The content and structure align with a Management Discussion and Analysis (MD&A) report, which is a detailed explanation of financial results and business trends for a period shorter than a full fiscal year. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2020
2020-01-09 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.